Infectious Diseases in Critical Care Medicine

Intra-abdominal surgical infections
acalculous cholecystitis, 263–264
antibiotic-associatedClostridium difficilediarrhea,
in ICU patient, 262–263
bloodstream infection, 268
colorectal anastomotic leakage, 264–265
de novo coincidental, 269
early recognition, 260–261
microbiology, 261
mimics of, 268
pancreatitis
diagnosis, 267
prophylaxis, 267–268
treatment, 267–268
pathogenesis, 261
perforated gastroduodenal ulcer, 265
in SOT recipients, 397
spontaneous bacterial peritonitis (SBP), 265–267
treatment, 261–262
Intraerythrocytic protozoan, 352
Intranasal eschar.SeeEschar
Intravenous drug abuser IE (IVDA IE), 220,
223, 227, 231.See alsoInfective
endocarditis (IE)
Intravenous drug abusers (IVDA), 503
Intravenous immunoglobulins (IVIGs), 304
Invasive aspergillosis (IA), 394
IRD.SeeImmune reconstitution disease (IRD)
Ischemic colitis, 85
Isospora belli, 400
ISTM.SeeInternational Society of Travel Medicine
(ISTM)
IVDA.SeeIntravenous drug abusers (IVDA)
IVDA IE.SeeIntravenous drug abuser IE (IVDA IE)
IVIGs.SeeIntravenous immunoglobulins (IVIGs)
IV-line sepsis, 12
Ixodes, 157

JAK3.SeeAnti-Janus kinase 3 (JAK3)
Janeway lesions, 27
Japanese encephalitis, 91, 329
Jaundice, physical findings
diagnostic features, 58
noninfectious mimics, 58
PE findings, 58
JC virus
anti-TNF therapy and, 382

Katayama fever, 331
Kawasaki disease (KD), 35–36, 75
KD.SeeKawasaki disease (KD)
Keratitis
interstitial, 67
pseudodendritic, 71
Ketamine-induced coma, 481
Kidney transplantation (KT), 391, 394
Kingellaspp., 221

Klebsiella, 82, 84, 94

Klebsiella oxytoca, 277

Klebsiella pneumoniae, 170, 173, 222, 362, 488

KT.SeeKidney transplantation (KT)

Laboratory Risk Indicator for Necrotizing Fasciitis

(LRINEC) score, 303

b-lactam, 536, 544, 546

antibiotics, 103, 148, 528–529

cross reactions between penicillins, 537

in penicillin allergy, 536

b-lactam therapy

for IE, 241–242

for MSSA/MRSA ABE, 211

toxic shock syndrome and, 314

Lactate dehydrogenase (LDH)

CRF test, 147

Lactobacillusspp., 400

Laryngitis, 423

Lassa virus, 332

Latent tuberculosis infection (LTBI), 380

LDH.SeeLactate dehydrogenase (LDH)

Leapfrog Group, 487

Legionella, 164

infections, in SOT recipients, 393

pneumonia, 380

Legionella micdadei, 393

Legionella pneumophila, 326, 345, 393

Legionnaire’s disease, 161, 164, 170

Leishmaniasis, 405

Leptospirosis (Weil’s syndrome), 68, 331

Leukocyte-depleted red blood cell transfusion,

HAP and, 186

Leukocytosis, 137

Leukopenia, 130, 361, 546

Levofloxacin, 353, 530

with ventilatorassociated pneumonia, 530

Libman–Saks endocarditis, 211

Line-associated bacteremias, CVC infections

and, 208

Line sepsis

burn wound infections and, 371

Linezolid, 192–193, 538

in anemia, 546

in MRSA, 508

treatment of MRSA infections, 530

in vitro susceptibility testing, 508

in VRE, 508

Lipemia retinalis, 75

Listeria, 158

Listeriainfection, 380

Listeria monocytogenes, 135

infections in SOT recipients, 401

Listeriosis, 389

Liver

abscess

clinical and radiologic diagnosis of, 80

mimic of, 81

Index 569